EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Cellnex (CLNX SM) Spain

Industrials

Insight Investment Research

Robert Crimes views CLNX’s sharp de-rating since 2022 as highly unjustified. Prop. EBITDaL has grown 36%, from €1.8bn in 2022 to €2.4bn in 2025E, yet the share price has declined 26%, massively underperforming the Eurofirst 300. The stock trades on 2025E EV/EBITDaL of 16.7x, a 29% discount to the 22.9x average of its recent disposals. Robert believes CLNX could attract a buyout from a large consortium, such as American Tower, as it offers a non-replicable pan-European network, ranking first or second in eight of the ten countries it operates in. His TP of €69, implies ~135% upside, with CLNX ranking 3rd of 23 on Insight’s Stock Ranking System.

Edition: 221

- 03 October, 2025


Entering the end game of 3 independent TowerCos in Europe

Industrials

Insight Investment Research

Robert Crimes’ 16-page report details how the European Towers market is to undergo a final phase of consolidation with several large transactions resulting in 3 dominant TowerCos - Cellnex, Vantage Towers and American Tower Europe. He notes that it is significantly more efficient for MNOs to share passive infrastructure while Tower transaction valuations have recently risen allowing MNOs to generate large capital releases to fund investment in 5G and de-lever balance sheets (potential to monetise a further €85bn of Tower assets in Europe). Robert’s preferred stock is Cellnex (well placed to continue to grow acquisitively, raise tenancy and returns); TP €106 (+145%).

Edition: 127

- 21 January, 2022